NEP INTERLONG (08329) Sets 25 Mar 2025 Board Meeting to Approve FY2025 Results and Consider Final Dividend

Bulletin Express03-11

Shenzhen Neptunus Interlong Bio-technique Company Limited (NEP INTERLONG, 08329) has scheduled a board meeting for 25 March 2025 at 11:00 a.m. in Shenzhen.

Key agenda items:

1. Review and approve the audited consolidated results for the year ended 31 December 2025, along with the accompanying results announcement for publication on the websites of GEM and the company.

2. Deliberate on the payment of a final dividend.

3. Consider the possible closure period for the Register of Members.

4. Address any other business matters.

The meeting will be held in the company’s headquarters at the Neptunus Yinhe Technology Mansion, Nanshan District, Shenzhen.

The notice was signed by Chairman Zhang Feng and dated 11 March 2026. The current board comprises three executive directors, three non-executive directors and three independent non-executive directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment